207 related articles for article (PubMed ID: 36190188)
1. Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation [ECCO] Position Paper.
Hanzel J; Bossuyt P; Pittet V; Samaan M; Tripathi M; Czuber-Dochan W; Burisch J; Leone S; Saldaña R; Baert F; Kopylov U; Jäghult S; Adamina M; Arebi N; Gecse K
J Crohns Colitis; 2023 Apr; 17(3):311-317. PubMed ID: 36190188
[TBL] [Abstract][Full Text] [Related]
2. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
; Ma C; Hanzel J; Panaccione R; Sandborn WJ; D'Haens GR; Ahuja V; Atreya R; Bernstein CN; Bossuyt P; Bressler B; Bryant RV; Cohen B; Colombel JF; Danese S; Dignass A; Dubinsky MC; Fleshner PR; Gearry RB; Hanauer SB; Hart A; Kotze PG; Kucharzik T; Lakatos PL; Leong RW; Magro F; Panés J; Peyrin-Biroulet L; Ran Z; Regueiro M; Singh S; Spinelli A; Steinhart AH; Travis SP; van der Woude CJ; Yacyshyn B; Yamamoto T; Allez M; Bemelman WA; Lightner AL; Louis E; Rubin DT; Scherl EJ; Siegel CA; Silverberg MS; Vermeire S; Parker CE; McFarlane SC; Guizzetti L; Smith MI; Vande Casteele N; Feagan BG; Jairath V
Gastroenterology; 2022 Oct; 163(4):950-964. PubMed ID: 35788348
[TBL] [Abstract][Full Text] [Related]
3. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
[TBL] [Abstract][Full Text] [Related]
4. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
5. A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence.
Wong C; van Oostrom J; Bossuyt P; Pittet V; Hanzel J; Samaan M; Tripathi M; Czuber-Dochan W; Burisch J; Leone S; Saldaña R; Baert F; Kopylov U; Jaghult S; Adamina M; Gecse K; Arebi N
J Crohns Colitis; 2022 Nov; 16(10):1511-1522. PubMed ID: 35512352
[TBL] [Abstract][Full Text] [Related]
6. High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
Bodelier AG; Jonkers D; van den Heuvel T; de Boer E; Hameeteman W; Masclee AA; Pierik MJ
Dig Dis Sci; 2017 Feb; 62(2):465-472. PubMed ID: 27933473
[TBL] [Abstract][Full Text] [Related]
7. Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn's and Colitis Organisation [ECCO] Position Paper.
Fiorino G; Lytras T; Younge L; Fidalgo C; Coenen S; Chaparro M; Allocca M; Arnott I; Bossuyt P; Burisch J; Campmans-Kuijpers M; de Ridder L; Dignass A; Drohan C; Feakins R; Gilardi D; Grosek J; Groß E; Hart A; Jäghult S; Katsanos K; Lönnfors S; Panis Y; Perovic M; Pierik M; Rimola J; Tulchinsky H; Gisbert JP
J Crohns Colitis; 2020 Sep; 14(8):1037-1048. PubMed ID: 32032423
[TBL] [Abstract][Full Text] [Related]
8. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
9. The Toronto IBD Global Endoscopic Reporting [TIGER] Score: A Single, Easy to Use Endoscopic Score for Both Crohn's Disease and Ulcerative Colitis Patients.
Zittan E; Steinhart AH; Aran H; Milgrom R; Gralnek IM; Zelber-Sagi S; Silverberg MS
J Crohns Colitis; 2022 May; 16(4):544-553. PubMed ID: 34272937
[TBL] [Abstract][Full Text] [Related]
10. Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience.
Erdoğan Ç; Yeşil B; Bacaksız F; Arı D; Gökbulut V; Yüksel M; Özderin Özin Y; Kayaçetin E
Turk J Gastroenterol; 2022 Oct; 33(10):831-837. PubMed ID: 35946879
[TBL] [Abstract][Full Text] [Related]
11. Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study.
Negm M; Bahaa A; Farrag A; Lithy RM; Badary HA; Essam M; Kamel S; Sakr M; Abd El Aaty W; Shamkh M; Basiony A; Dawoud I; Shehab H
BMC Gastroenterol; 2022 Apr; 22(1):203. PubMed ID: 35462542
[TBL] [Abstract][Full Text] [Related]
12. Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort.
Plevris N; Chuah CS; Allen RM; Arnott ID; Brennan PN; Chaudhary S; Churchhouse AMD; Din S; Donoghue E; Gaya DR; Groome M; Jafferbhoy HM; Jenkinson PW; Lam WL; Lyons M; Macdonald JC; MacMaster M; Mowat C; Naismith GD; Potts LF; Saffouri E; Seenan JP; Sengupta A; Shasi P; Sutherland DI; Todd JA; Veryan J; Watson AJM; Watts DA; Jones GR; Lees CW
J Crohns Colitis; 2019 Sep; 13(9):1111-1120. PubMed ID: 30768123
[TBL] [Abstract][Full Text] [Related]
13. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
Falvey JD; Hoskin T; Meijer B; Ashcroft A; Walmsley R; Day AS; Gearry RB
Inflamm Bowel Dis; 2015 Apr; 21(4):824-31. PubMed ID: 25738372
[TBL] [Abstract][Full Text] [Related]
14. Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units.
Calvet X; Panés J; Alfaro N; Hinojosa J; Sicilia B; Gallego M; Pérez I; Lázaro y de Mercado P; Gomollón F; ; Aldeguera X; Alós R; Andreu M; Barreiro M; Bermejo F; Casis B; Domenech E; Espín E; Esteve M; García-Sánchez V; López-Sanromán A; Martínez-Montiel P; Luis Mendoza J; Gisbert JP; Vera M; Dosal A; Sánchez E; Marín L; Sanromán L; Pinilla P; Murciano F; Torrejón A; Ramón García J; Ortega M; Roldán J
J Crohns Colitis; 2014 Mar; 8(3):240-51. PubMed ID: 24295646
[TBL] [Abstract][Full Text] [Related]
15. Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists.
Daperno M; Comberlato M; Bossa F; Armuzzi A; Biancone L; Bonanomi AG; Cassinotti A; Cosintino R; Lombardi G; Mangiarotti R; Papa A; Pica R; Grassano L; Pagana G; D'Incà R; Orlando A; Rizzello F;
J Crohns Colitis; 2017 May; 11(5):556-561. PubMed ID: 28453758
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
17. Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease.
Swaminathan A; Borichevsky GM; Edwards TS; Hirschfeld E; Mules TC; Frampton CMA; Day AS; Hampton MB; Kettle AJ; Gearry RB
J Crohns Colitis; 2022 Dec; 16(12):1862-1873. PubMed ID: 35803583
[TBL] [Abstract][Full Text] [Related]
18. BRAZILIAN CONSENSUS ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN PEDIATRIC PATIENTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Lomazi EA; Oba J; Rodrigues M; Marmo MCDR; Sandy NS; Sdepanian VL; Imbrizi M; Baima JP; Magro DO; Albuquerque IC; Zabot GP; Cassol OS; Saad-Hossne R
Arq Gastroenterol; 2023; 59(suppl 1):85-124. PubMed ID: 36995890
[TBL] [Abstract][Full Text] [Related]
19. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
Boon GJ; Day AS; Mulder CJ; Gearry RB
World J Gastroenterol; 2015 Oct; 21(40):11469-80. PubMed ID: 26523111
[TBL] [Abstract][Full Text] [Related]
20. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
